Fermenta Biotech informs about outcome of board meeting

12 Feb 2020 Evaluate

Fermenta Biotech has informed that the Board of Directors of the Company at its meeting held on February 12, 2020 has approved the unaudited financial results for the quarter and nine months ended December 31, 2019 (Standalone and Consolidated) as enclosed. Also enclosed Limited Review Report dated February 12, 2020 (along with the aforesaid Consolidated and Standalone unaudited financial Results) issued by the Company's Statutory Auditors, Deloitte Haskins & Sells LLP. The Board meeting commenced at 10:45 am and concluded at 12:55 pm.

The above information is a part of company’s filings submitted to BSE.

Fermenta Biotech Share Price

269.00 4.45 (1.68%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×